Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.

MLA

Paul, Subroto, et al. “Survival of Patients with Clinical Stage IIIA Non-Small Cell Lung Cancer after Induction Therapy: Age, Mediastinal Downstaging, and Extent of Pulmonary Resection as Independent Predictors.” The Journal of Thoracic and Cardiovascular Surgery, vol. 141, no. 1, Jan. 2011, pp. 48–58. EBSCOhost, https://doi.org/10.1016/j.jtcvs.2010.07.092.

APA

Paul, S., Mirza, F., Port, J. L., Lee, P. C., Stiles, B. M., Kansler, A. L., & Altorki, N. K. (2011). Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors. The Journal of Thoracic and Cardiovascular Surgery, 141(1), 48–58. https://doi.org/10.1016/j.jtcvs.2010.07.092

Chicago

Paul, Subroto, Farooq Mirza, Jeffrey L Port, Paul C Lee, Brendon M Stiles, Amanda L Kansler, and Nasser K Altorki. 2011. “Survival of Patients with Clinical Stage IIIA Non-Small Cell Lung Cancer after Induction Therapy: Age, Mediastinal Downstaging, and Extent of Pulmonary Resection as Independent Predictors.” The Journal of Thoracic and Cardiovascular Surgery 141 (1): 48–58. doi:10.1016/j.jtcvs.2010.07.092.